Evidence map›Paper›PMID 38461311›Full record

ArticleNature communications2024

Drivers and impact of the early silent invasion of SARS-CoV-2 Alpha.

Benjamin Faucher, Chiara E Sabbatini, Peter Czuppon, Moritz U G Kraemer, Philippe Lemey, Vittoria Colizza, François Blanquart, Pierre-Yves Boëlle, Chiara Poletto

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Benjamin FaucherSorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (IPLESP), F75012, Paris, France.
Chiara E SabbatiniSorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (IPLESP), F75012, Paris, France.
Peter CzupponInstitute for Evolution and Biodiversity, University of Münster, Münster, 48149, Germany.ORCID 0000-0003-1462-7237
Moritz U G KraemerDepartment of Biology, University of Oxford, Oxford, UK.
Philippe LemeyDepartment of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory for Clinical and Epidemiological Virology, KU Leuven, Leuven, Belgium.ORCID 0000-0003-2826-5353
Vittoria Colizza *Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (IPLESP), F75012, Paris, France.ORCID 0000-0002-2113-2374
François Blanquart *Center for Interdisciplinary Research in Biology, CNRS, Collège de France, PSL Research University, Paris, 75005, France.
Pierre-Yves Boëlle *Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (IPLESP), F75012, Paris, France.
Chiara Poletto *Department of Molecular Medicine, University of Padova, 35121, Padova, Italy. chiara.poletto@unipd.it.ORCID 0000-0002-4051-1716

Funding

Agence Nationale de la Recherche (French National Research Agency) ANR-19-CE46-0008-03Agence Nationale de Recherches sur le Sida et les Hépatites Virales (National Agency for AIDS Research) ANRS0151
6 · The paper itself

Abstract

SARS-CoV-2 variants of concern (VOCs) circulated cryptically before being identified as a threat, delaying interventions. Here we studied the drivers of such silent spread and its epidemic impact to inform future response planning. We focused on Alpha spread out of the UK. We integrated spatio-temporal records of international mobility, local epidemic growth and genomic surveillance into a Bayesian framework to reconstruct the first three months after Alpha emergence. We found that silent circulation lasted from days to months and decreased with the logarithm of sequencing coverage. Social restrictions in some countries likely delayed the establishment of local transmission, mitigating the negative consequences of late detection. Revisiting the initial spread of Alpha supports local mitigation at the destination in case of emerging events.

Indexed as

COVID-19EpidemicsBayes TheoremHumansSARS-CoV-2

Identifiers

PMID38461311
PMCPMC10925057

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.